Last updated on March 2019

A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema


Brief description of study

A two part, multi-center study consisting of a Phase 1b open label, sequential dose escalation followed by a Phase 2a randomized, double-masked, dose expansion evaluating OPT-302 in combination with aflibercept in participants with persistent central-involved Diabetic Macular Edema.

Clinical Study Identifier: NCT03397264

Find a site near you

Start Over

Opthea Investigational Site

Phoenix, AZ United States
  Connect »

Opthea Investigational Site

Bakersfield, CA United States
  Connect »

Opthea Investigational Site

Fort Myers, FL United States
  Connect »

Opthea Investigational Site

Wichita, KS United States
  Connect »

Opthea Investigational Site

Charlotte, NC United States
  Connect »

Opthea Investigational Site

West Columbia, SC United States
  Connect »

Opthea Investigational Site

Beverly Hills, CA United States
  Connect »

Opthea Investigational Site

Sacramento, CA United States
  Connect »

Opthea Investigational Site

Santa Ana, CA United States
  Connect »

Opthea Investigational Site

Colorado Springs, CO United States
  Connect »

Opthea Investigational Site

Melbourne, FL United States
  Connect »

Opthea Investigational Site

Pensacola, FL United States
  Connect »

Opthea Investigational Site

Asheville, NC United States
  Connect »

Opthea Investigational Site

Youngstown, OH United States
  Connect »

Opthea Investigational Site

Abilene, TX United States
  Connect »

Opthea Investigational Site

San Antonio, TX United States
  Connect »

Opthea Investigational Site

Willow Park, TX United States
  Connect »

Opthea Investigational Site

Redlands, CA United States
  Connect »

Opthea Investigational Site

Boynton Beach, FL United States
  Connect »

Opthea Investigational Site

Saint Petersburg, FL United States
  Connect »

Opthea Investigational Site

Augusta, GA United States
  Connect »

Opthea Investigational Site

Indianapolis, IN United States
  Connect »

Opthea Investigational Site

Des Moines, IA United States
  Connect »

Opthea Investigational Site

Hagerstown, MD United States
  Connect »

Opthea Investigational Site

Las Vegas, NV United States
  Connect »

Opthea Investigational Site

Portland, OR United States
  Connect »

Opthea Investigational Site

Charleston, SC United States
  Connect »

Opthea Investigational Site

Rapid City, SD United States
  Connect »

Opthea Investigational Site

Germantown, TN United States
  Connect »

Opthea Investigational Site

Arlington, TX United States
  Connect »

Opthea Investigational Site

Houston, TX United States
  Connect »

Opthea Investigational Site

McAllen, TX United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.